RecruitingNCT05989620
Long-Term Development of Muscular Dystrophy Outcome Assessments
Long-Term Development of Muscular Dystrophy Outcome Assessments (GRASP-01-005)
Sponsor
Virginia Commonwealth University
Enrollment
1,000 participants
Start Date
Oct 18, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
This is a 24-month, observational study of up to 1000 participants with Limb Girdle Muscular Dystrophy (LGMD), Myotonic Dystrophy Type 2 (DM2), and late onset Pompe disease (LOPD).
Eligibility
Min Age: 6 YearsMax Age: 50 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a new treatment for people with lgmd1b, lgmd1c, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 6 Years to 50 Years.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05989620